Poor
Needs Revision
Patient Risk:
Moderate
Summary
Partially aligns with label-supported counseling on dizziness/somnolence and hypersensitivity/angioedema, but multiple caffeine/coffee-specific clinical claims (effects, timing, risk framing, symptom-driven advice, and dose/timing vs coffee contrast) are not supported by the provided FDA label sections.
Category Scores
Accurate Statements
Pregabalin can cause side effects such as dizziness and drowsiness.
Supported by 5.5 Dizziness and Somnolence and Patient Counseling (Dizziness and Somnolence).
The provided information does not specify interactions between pregabalin and caffeine/coffee.
Label states co-administration interactions are not systematically evaluated (7 Drug Interactions) and does not provide caffeine/coffee-specific guidance in the supplied sections.
The provided information does not cover whether coffee/caffeine changes pregabalin’s effectiveness.
No caffeine/coffee effectiveness effect is addressed in the supplied label sections (7 Drug Interactions).
Unsupported Statements
Coffee may temporarily reduce the sense of sleepiness for some people.
Not supported/absent from the provided label sections.
Pregabalin’s effects can impair reaction time and coordination.
The label (5.5 and counseling) supports effects impairing ability to perform tasks such as driving/operating machinery, but the specific framing of “reaction time and coordination” is not clearly stated in the provided text.
Even if coffee makes a person feel more awake, they may still be at higher risk of feeling off-balance or tired later, especially after coffee wears off.
Coffee/temporal risk framing is absent from the provided label sections.
Effectiveness of pregabalin used for nerve pain or seizure-related indications is more likely to depend on the pregabalin dose and timing rather than coffee intake.
The label excerpt does not address coffee as a factor affecting effectiveness; caffeine/coffee-contrast claim is not supported.
Individual tolerance varies for pregabalin effectiveness.
Not supported/absent from the provided label sections.
If coffee increases jitteriness, anxiety, tremor, or dizziness, cutting back or stopping and discussing it with a clinician is advised in the provided information.
Caffeine/coffee symptom-specific advice and behavioral management is absent from the provided label sections.
Get urgent help for severe dizziness, fainting, confusion, or signs of an allergic reaction such as swelling of the face/lips and trouble breathing.
Angioedema/hypersensitivity symptoms are label-supported, but the specific combination of severe dizziness/fainting/confusion and the exact “face/lips” phrasing as urgent triggers is not fully anchored to the provided label text.
Contact a healthcare professional if there are mood changes, new/worsening agitation, or unusually sedation despite coffee.
Mood/agitation counseling is label-supported in general, but the “despite coffee” condition is not supported.
Contradictions
Low
AI Statement
Coffee makes a person feel more awake, but pregabalin-related impairment persists and later off-balance/tiredness risk is higher after coffee wears off.
Label Reference
No provided label statement supports coffee altering pregabalin-related impairment timing or risk; treated as unsupported rather than directly contradictory.
Important Omissions
CNS depressant/additive effects and alcohol avoidance counseling are not mentioned in the claims provided.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Coffee-specific claims and symptom-driven advice (reduce/stop coffee) are not label-supported and could lead patients to act on non-labeled caffeine-related interpretations rather than on label-supported pregabalin precautions. Label-supported urgent counseling for angioedema/hypersensitivity is partially included.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Needs Revision
Primary Issue
Multiple unsupported caffeine/coffee-specific clinical assertions and advice are included; label-supported counseling should not be conditionally reframed around coffee timing/effects.
Suggested Improvement
Remove or neutralize all coffee/caffeine-specific effect/timing/risk-management claims. Keep only label-anchored statements: pregabalin may cause dizziness and somnolence impairing driving/operating machinery; counsel on angioedema/hypersensitivity and when to seek emergency care based on those label-defined symptoms; optionally include label-supported CNS depressant/alcohol cautions from the provided labeling if relevant.